Regeneron Pharmaceuticals REGN Dupixent Secures FDA Approval as First Biologic for Pediatric Chronic Spontaneous Urticaria Expanding Blockbuster Drugs Addressable Market AOSL AO Semi beats quarterly loss estimates by 18 percent shares rise 2 percent on investor optimism SAP SAP SE ADS notches 37 percent Q4 2025 EPS beat but shares slip 173 percent in todays trading State Street Materials Select Sector SPDR ETF XLB 2026 Investment Case Analysis and Sector Peer Comparison VOYAB Voya undisclosed quarterly earnings metrics leave investors seeking clarity on preferred share performance Coastal Erosion Threatens UK Infrastructure Assets Roads Homes and Railways at Risk Hindalco Q4 Net Profit Falls 51 on Novelis Fire Expenses Revenue Jumps 20 on Higher Metal Prices Este Lauder Abandons Merger Talks with Spanish Beauty Rival Puig Bill Gates Discusses Meeting with Trump Elon Musks DOGE Initiatives and Childhood in Upcoming Book BofA Lifts Pfizer Price Target Following Strong Q1 Performance Reddit Shares Slide Nearly 6 After Meta Launches New Forum App Intensifying Competitive Pressure MNR Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment GATX Q1 2026 Earnings EPS Beats Estimates as Railcar Leasing Portfolio Holds Steady MOLN Q4 2025 Earnings Positive EPS Surprise Amid No Revenue CZFS Q1 2026 Earnings EPS Beat of 695 Lifts Shares as Revenue Details Remain Undisclosed DSGN Q1 2026 Earnings EPS Beats Estimates as Development Stage Biotech Advances Pipeline Nordic American Tankers Limited Q4 2025 Earnings EPS Misses Estimates by 56 as Tanker Market Faces Headwinds